Health minister faces calls for dismissal over Lyrica shortage
Liliana Ruse, a journalist with cancer, wrote that she cannot get hold of the medication that eases the nerve problems caused by chemotherapy. Health Minister Alexandru Rogobete responded with national stock data to argue that the drug has not disappeared from the market, warning of the danger of causing panic — yet the medicines agency had been informed of supply disruptions months earlier, and the ministry's own inspection found that recorded stock levels can easily diverge from reality.
Liliana Ruse, a journalist with Digi24, wrote on Facebook on Sunday, November 15, that she had searched in vain for Lyrica, which contains the active ingredient pregabalin, and its generic versions. According to her account, the drug helps her use her hands and feet, which have gone numb as a result of chemotherapy; so when she called the state "guilty" over the supply situation, she was speaking about her own illness and about a shortage that makes her daily life harder. Rogobete responded within a few hours; although he did not name the journalist, he called false the claim that Lyrica and products with the same active ingredient had disappeared from the Romanian market, and then listed the stocks reported on November 13: wholesalers held 922,627 units and retail pharmacies held 1,429,818, for a total of 2,352,445 units of medication. Of these, 645,834 were Lyrica, adding up the 75, 150 and 300 milligram versions. The figures referred to units of medication, not an equal number of boxes. The minister acknowledged that some pharmacies may temporarily lack a given product, but said this does not amount to a nationwide shortage. He also called for responsible, verified information, so that such statements would not cause panic. Ruse's reply made clear just how little comfort she took from the list. She felt the minister was essentially portraying her as delusional, so she proposed a very simple test: she offered to give Rogobete the money if he would just buy her a box in Bucharest. "I'm waiting," she wrote at the end of her post.
The dispute soon moved beyond the fact that a patient and a minister were experiencing the drug supply differently. Radu Miruță, a former minister from USR, dug up the public registry of the National Medicines Agency, in which Lyrica is listed among the products affected by temporary supply disruptions. The suspension of deliveries of the 150 milligram version, running from June to December, was announced on May 15, while the authority was notified on September 18 about the shortfall of the 75 milligram version, due to start in November. According to Miruță, between August and November, temporary supply problems were also reported for five other generic pregabalin products, meaning officials had known for months that trouble might be coming. This was precisely what Miruță held against Rogobete: in his view, the ministry had known about the problem for half a year, yet it took a patient's public complaint to make the minister urgently pull up an Excel spreadsheet.
A manufacturer's notification by itself does not, of course, mean that the very last box of the drug in the country has run out, but it does mean that this is a known, anticipated supply problem that cannot be waved away with a national total. This is especially true given that the ministry itself knows that the registry does not necessarily show accurately what is actually available to patients. This was pointed out by DeFapt.ro, which dug up the ministry's inspection summary published on October 7. According to the document, the automation of the electronic reporting system, SER, is not sufficient to identify in real time the risks related to stock levels, consumption and data reporting; monitoring relies to a significant extent on manual analysis and incoming complaints, and public information about supply disruptions is not always complete or up to date. The inspection specifically flagged as a risk the fact that discrepancies between actual stocks and reported quantities can go unnoticed.
The experience of pharmacists makes the same problem tangible. Beatrice Speteanu, head of the association representing traditional pharmacies and the professionals who run them, told News.ro that the system can include products that have expired or were earmarked for export from the outset, and that adding up stocks of different strengths from different manufacturers can mask the fact that there isn't enough of the specific drug needed to fill a given prescription. What matters to the patient is whether they can get the treatment they were prescribed; the national total can still show a reassuring figure regardless.
On Monday, the Association of Pharmacies and Pharmacists of Romania, AFFR, also reported that Lyrica is available only in limited quantities at its member companies. Voluntary reports indicated stocks in eight counties — Prahova, Dâmbovița, Iași, Galați, Brăila, Tulcea, Constanța and Argeș — while Bucharest and Ilfov were not included in the list. This is not a complete nationwide survey, as the association itself stressed, but it illustrates well the difference between some medication still being left somewhere and patients being able to reliably get hold of it.
Vlad Voiculescu, a former health minister, USR member of the European Parliament and honorary adviser to the president, also criticized Rogobete's conduct. He said it was unacceptable for the minister to lecture a cancer patient while the institution under his own authority keeps the record of supply disruptions. He also recalled that in 2016, as a minister in the Cioloș government, he launched a portal for reporting drug shortages: under the procedure adopted at the time, a report had to be examined within four working days, and the person who filed it had to be informed within seven days about the planned measures. According to Voiculescu, this platform was later shut down during Alexandru Rafila's term as minister, while Rogobete served as state secretary. Meanwhile, Rogobete himself has also spoken about the supply problems. In another statement on Sunday, he acknowledged that some medications are available in warehouses but are not reaching pharmacies, and he also mentioned disruptions on the manufacturers' side. These will only amount to real help once patients can see the results for themselves at the pharmacy. Until then, Ruse's offer remains a fairly precise measure of the minister's response: if the supply situation is really as reassuring as claimed, it should be possible to buy a box in Bucharest. There is hardly a more convincing answer to a patient's complaint than for her to finally get hold of her medication.
Ugar
Did you like this article?
Support our work with a small donation
Secure payment via Stripe • Min. 2 EUR
Gesta recommendations:

Europe wants to replace Palantir, Musk showed why in Ukraine
European defense ministries want to reduce their dependence on key military tasks on the American company Palantir Technologies and other American technology firms, and an increasing number of European companies are competing for the market being vacated. Germany, France and the Netherlands are all building their own European systems for what Palantir's software has been used for or would have…

We receive the chemicals that disrupt our hormonal system even before we are born
Chemicals that disrupt the human hormonal system are now present almost everywhere in our environment: in plastics, cosmetics, toys and pesticides, and researchers have detected them in human blood, breast milk and umbilical cord blood. This means that exposure begins even before birth. This is revealed in a joint report by the United Nations Environment Programme (UNEP) and the World Health…

Oops: NSA's secret network goes down
A few days after Microsoft's worldwide outage and the flight ban that paralyzed American airports, service was also interrupted in one of the United States' most sensitive IT systems: the strictly classified internal network through which employees of the National Security Agency (NSA) share classified information went down. No connection has so far been established between the failures, and at…

Lasconi would support an alliance between the PNL and the USR, but fears that everyone will once again want too much
Elena Lasconi believes it would do Romania's right wing good if the PNL and the USR joined forces and tried to win back the trust of voters disillusioned with the parties under a new name, but she is less convinced that such an agreement could actually come about. The former USR leader explained her doubts by drawing on her own experience from her presidential campaign, recalling that in…

20 years in the EU: Negrescu calls for a new European plan for Romania
Twenty years after Romania and Bulgaria joined the European Union on January 1, 2007, Victor Negrescu, the PSD vice-president of the European Parliament, says Romania needs a new European programme that unites the political class and civil society. “We need a new European project for our country, a European plan for Romania,” he said at the European Parliament's building in Brussels, at the event…